公司資料
Gossamer Bio 股價、新聞與催化劑
- 股票代碼:
- GOSS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.17 USD (+13.12%)
收盤價
最後更新: 2026年8月24日
47M USD
市值
股價為何變動
As of Aug 24, 2026, GOSS closed up 13.1% at $0.1750. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Gossamer Bio is a biotechnology company focused on pulmonary and inflammatory disease. Its programs aim to address serious conditions in areas where targeted therapies can matter.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Gossamer sits in specialty biotechnology.
商業模式特徵
The company depends on clinical data, target validation, and the ability to build a focused respiratory and inflammation franchise.
生技產業定位
Gossamer is a catalyst-sensitive specialty name whose stock reacts to data, strategy, and execution.
未來催化劑
- Gossamer’s catalysts are seralutinib and the pulmonary-hypertension program, with the next update deciding whether the inhaled therapy can still build momentum. The company needs clean clinical progress to keep the story moving.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。